Wang, L., Zhang, J., Wang, S., Dong, S., Qiu, X., Zhao, L., Yin, Z., Luo, K., Qu, C., Fu, X., Liu, B., Wang, J., Xue, Y., Zhang, S., Yu, L., Guo, R., Guo, J., Song, R., Zhang, L., Shi, Y. (2025). Ensartinib as postoperative adjuvant therapy in patients with ALK-positive non-small cell lung cancer (NSCLC): A registered, retrospective, real-world study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8024